Large-scale testing (Phase 3)Active Not RecruitingNCT05438407What this trial is testingPediatric Patients Aged 4 to 11 Years With APDSWho this might be right forAPDS Pharming Technologies B.V. 15
Testing effectiveness (Phase 2)Study completedNCT03383380What this trial is testingRapamycin Treatment for Activated Phosphoinositide 3-Kinase δ SyndromeWho this might be right forActivated PI3K-delta SyndromeImmunodeficiency Primary Children's Hospital of Fudan University 30
Large-scale testing (Phase 3)Ended earlyNCT02859727What this trial is testingExtension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLIWho this might be right forActivated PI3Kdelta Syndrome (APDS); PASLI Disease Pharming Technologies B.V. 37
Large-scale testing (Phase 3)Study completedNCT02435173What this trial is testingStudy of Efficacy of CDZ173 in Patients With APDS/PASLIWho this might be right forCommon Variable Immunodeficiency (CVID), APDS / PASLI Novartis Pharmaceuticals 37
Large-scale testing (Phase 3)Active Not RecruitingNCT05693129What this trial is testingPediatric Patients Aged 1 to 6 Years With APDSWho this might be right forAPDS Pharming Technologies B.V. 16
Large-scale testing (Phase 3)UnknownNCT06249997What this trial is testingAn Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDSWho this might be right forAPDS Gene Mutation Pharming Technologies B.V. 3
Not applicableLooking for participantsNCT06694363What this trial is testingNew Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ SyndromeWho this might be right forActivated PI3K Delta Syndrome Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Study completedNCT02593539What this trial is testingSafety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLIWho this might be right forActivated PI3K-delta Syndrome GlaxoSmithKline 5